Ono Pharmaceutical Company Top Insiders

OPHLF Stock  USD 12.50  1.20  10.62%   
Ono Pharmaceutical employs about 3.7 K people. The company is managed by 10 executives with a total tenure of roughly 61 years, averaging almost 6.0 years of service per executive, having 368.7 employees per reported executive. Examination of Ono Pharmaceutical's management performance can provide insight into the company performance.
Gyo Sagara  CEO
CEO and President and Representative Director
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ono Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Ono Pharmaceutical Management Team Effectiveness

The company has return on total asset (ROA) of 0.1204 % which means that it generated a profit of $0.1204 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1605 %, meaning that it generated $0.1605 on every $100 dollars invested by stockholders. Ono Pharmaceutical's management efficiency ratios could be used to measure how well Ono Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.

Ono Pharmaceutical Workforce Comparison

Ono Pharmaceutical Co is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is now estimated at about 307,832. Ono Pharmaceutical claims roughly 3,687 in number of employees contributing just under 2% to equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.26 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.35 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.35.

Ono Pharmaceutical Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Ono Pharmaceutical Price Series Summation is a cross summation of Ono Pharmaceutical price series and its benchmark/peer.

Ono Pharmaceutical Notable Stakeholders

An Ono Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Ono Pharmaceutical often face trade-offs trying to please all of them. Ono Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Ono Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Gyo SagaraCEO and President and Representative DirectorProfile
Hiromu HabashitaExecutive Officer, Chief Director of ResearchProfile
Katsuji TeranishiHead of Marketing Strategy Planning, Deputy Director of Sales and Marketingl and Corporate OfficerProfile
Toshihiro TsujinakaExecutive Officer, Senior Director of Oncology in Main Sales UnitProfile
Hiroshi IchikawaSr. Director of Metropolitan Area Management and Metropolitan Area First Branch and Corporate OfficerProfile
Isao OnoExecutive Officer, Manager of Environmental Management Office, DirectorProfile
Yukio TaniExecutive Officer, Director of Public RelationsProfile
Toichi TakinoExecutive Director of Corporate Devel. and Strategy and Corporate OfficerProfile
Shozo MatsuokaExecutive Officer, Manager of R & D Strategy OfficeProfile
Kiyoaki IdemitsuExec OfficerProfile

About Ono Pharmaceutical Management Performance

The success or failure of an entity such as Ono Pharmaceutical often depends on how effective the management is. Ono Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Ono management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Ono management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Ono Pharmaceutical Co., Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. The company was founded in 1717 and is headquartered in Osaka, Japan. Ono Pharmaceutical operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 3687 people.

Ono Pharmaceutical Workforce Analysis

Traditionally, organizations such as Ono Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Ono Pharmaceutical within its industry.

Ono Pharmaceutical Manpower Efficiency

Return on Ono Pharmaceutical Manpower

Revenue Per Employee98M
Revenue Per Executive36.1B
Net Income Per Employee21.8M
Net Income Per Executive8.1B

Complementary Tools for Ono Pink Sheet analysis

When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios